Literature DB >> 28447000

8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice.

Thomas W Rice1, Deepa T Patil2, Eugene H Blackstone1,3.   

Abstract

The 8th edition of the American Joint Committee on Cancer (AJCC) staging of epithelial cancers of the esophagus and esophagogastric junction (EGJ) presents separate classifications for clinical (cTNM), pathologic (pTNM), and postneoadjuvant (ypTNM) stage groups. Histopathologic cell type markedly affects survival of clinically and pathologically staged patients, requiring separate groupings for each cell type, but ypTNM groupings are identical for both cell types. Clinical categories, typically obtained by imaging with minimal histologic information, are limited by resolution of each method. Strengths and shortcomings of clinical staging methods should be recognized. Complementary cytology or histopathology findings may augment imaging and aid initial treatment decision-making. However, prognostication using clinical stage groups remains coarse and inaccurate compared with pTNM. Pathologic staging is losing its relevance for advanced-stage cancer as neoadjuvant therapy replaces esophagectomy alone. However, it remains relevant for early-stage cancers and as a staging and survival reference point. Although pathologic stage could facilitate decision-making, its use to direct postoperative adjuvant therapy awaits more effective treatment. Prognostication using pathologic stage groups is the most refined of all classifications. Postneoadjuvant staging (ypTNM) is introduced by the AJCC but not adopted by the Union for International Cancer Control (UICC). Drivers of this addition include absence of equivalent pathologic (pTNM) categories for categories peculiar to the postneoadjuvant state (ypT0N0-3M0 and ypTisN0-3M0), dissimilar stage group compositions, and markedly different survival profiles. Thus, prognostication is specific for patients undergoing neoadjuvant therapy. The role of ypTNM classification in additional treatment decision-making is currently limited. Precision cancer care advances are necessary for this information to be clinically useful.

Entities:  

Keywords:  Clinical stage; decision-making; pathologic stage; postneoadjuvant stage; precision cancer care; prognostication

Year:  2017        PMID: 28447000      PMCID: PMC5387145          DOI: 10.21037/acs.2017.03.14

Source DB:  PubMed          Journal:  Ann Cardiothorac Surg        ISSN: 2225-319X


  47 in total

Review 1.  The endoscopic diagnosis and staging of oesophageal adenocarcinoma.

Authors:  Jacques J G H M Bergman
Journal:  Best Pract Res Clin Gastroenterol       Date:  2006       Impact factor: 3.043

2.  T2N0M0 esophageal cancer.

Authors:  Thomas W Rice; David P Mason; Sudish C Murthy; Gregory Zuccaro; David J Adelstein; Lisa A Rybicki; Eugene H Blackstone
Journal:  J Thorac Cardiovasc Surg       Date:  2007-01-09       Impact factor: 5.209

Review 3.  Diagnosis and staging of cancer of the esophagus and esophagogastric junction.

Authors:  Zhigang Li; Thomas W Rice
Journal:  Surg Clin North Am       Date:  2012-10       Impact factor: 2.741

4.  Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome.

Authors:  Tsung-Teh Wu; Lucian R Chirieac; Susan C Abraham; Alyssa M Krasinskas; Huamin Wang; Asif Rashid; Arlene M Correa; Wayne L Hofstetter; Jaffer A Ajani; Stephen G Swisher
Journal:  Am J Surg Pathol       Date:  2007-01       Impact factor: 6.394

5.  Treatment of clinical T2N0M0 esophageal cancer.

Authors:  Thomas J Hardacker; DuyKhanh Ceppa; Ikenna Okereke; Karen M Rieger; Shadia I Jalal; Julia K LeBlanc; John M DeWitt; Kenneth A Kesler; Thomas J Birdas
Journal:  Ann Surg Oncol       Date:  2014-07-22       Impact factor: 5.344

6.  Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival.

Authors:  A Koen Talsma; Joel Shapiro; Caspar W N Looman; Pieter van Hagen; Ewout W Steyerberg; Ate van der Gaast; Mark I van Berge Henegouwen; Bas P L Wijnhoven; J Jan B van Lanschot; Maarten C C M Hulshof; Hanneke W M van Laarhoven; Grard A P Nieuwenhuijzen; Geke A P Hospers; Johannes J Bonenkamp; Miguel A Cuesta; Reinoud J B Blaisse; Olivier R C Busch; Fiebo J W ten Kate; Geert-Jan Creemers; Cornelis J A Punt; John T M Plukker; Henk M W Verheul; Herman van Dekken; Maurice J C van der Sangen; Tom Rozema; Katharina Biermann; Jannet C Beukema; Anna H M Piet; Caroline M van Rij; Janny G Reinders; Hugo W Tilanus
Journal:  Ann Surg       Date:  2014-11       Impact factor: 12.969

7.  Fine-needle aspiration cytology guided by endoscopic ultrasonography: results in 141 patients.

Authors:  M Giovannini; J F Seitz; G Monges; H Perrier; I Rabbia
Journal:  Endoscopy       Date:  1995-02       Impact factor: 10.093

8.  ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus.

Authors:  Nicholas J Shaheen; Gary W Falk; Prasad G Iyer; Lauren B Gerson
Journal:  Am J Gastroenterol       Date:  2015-11-03       Impact factor: 10.864

Review 9.  Oesophageal adenocarcinoma and gastric cancer: should we mind the gap?

Authors:  Yoku Hayakawa; Nilay Sethi; Antonia R Sepulveda; Adam J Bass; Timothy C Wang
Journal:  Nat Rev Cancer       Date:  2016-04-26       Impact factor: 60.716

10.  Staging investigations for oesophageal cancer: a meta-analysis.

Authors:  E P M van Vliet; M H Heijenbrok-Kal; M G M Hunink; E J Kuipers; P D Siersema
Journal:  Br J Cancer       Date:  2008-01-22       Impact factor: 7.640

View more
  116 in total

1.  Comparison of Outcomes with Semi-mechanical and Circular Stapled Intrathoracic Esophagogastric Anastomosis following Esophagectomy.

Authors:  Fady Yanni; Pritam Singh; Nilanjana Tewari; Simon L Parsons; James A Catton; John Duffy; Neil T Welch; Ravinder S Vohra
Journal:  World J Surg       Date:  2019-10       Impact factor: 3.352

Review 2.  Oesophageal Squamous Dysplasia.

Authors:  Michael Auld; Havish Srinath; Eshwarshanker Jeyarajan
Journal:  J Gastrointest Cancer       Date:  2018-09

3.  Radiomics nomogram outperforms size criteria in discriminating lymph node metastasis in resectable esophageal squamous cell carcinoma.

Authors:  Xianzheng Tan; Zelan Ma; Lifen Yan; Weitao Ye; Zaiyi Liu; Changhong Liang
Journal:  Eur Radiol       Date:  2018-06-19       Impact factor: 5.315

4.  Comparing the 7th and 8th editions of the American Joint Committee on Cancer/Union for International Cancer Control TNM staging system for esophageal squamous cell carcinoma treated by definitive radiotherapy.

Authors:  Masahiro Inada; Yasumasa Nishimura; Kazuki Ishikawa; Kiyoshi Nakamatsu; Yutaro Wada; Takuya Uehara; Kohei Fukuda; Shimpei Anami; Hiroshi Doi; Shuichi Kanamori
Journal:  Esophagus       Date:  2019-05-20       Impact factor: 4.230

Review 5.  Eighth Edition of the UICC Classification of Malignant Tumours: an overview of the changes in the pathological TNM classification criteria-What has changed and why?

Authors:  Luca Bertero; Federica Massa; Jasna Metovic; Roberto Zanetti; Isabella Castellano; Umberto Ricardi; Mauro Papotti; Paola Cassoni
Journal:  Virchows Arch       Date:  2017-12-05       Impact factor: 4.064

6.  Volumetric Histogram Analysis of Apparent Diffusion Coefficient as a Biomarker to Predict Survival of Esophageal Cancer Patients.

Authors:  Atsushi Hirata; Koichi Hayano; Gaku Ohira; Shunsuke Imanishi; Toshiharu Hanaoka; Takeshi Toyozumi; Kentaro Murakami; Tomoyoshi Aoyagi; Kiyohiko Shuto; Hisahiro Matsubara
Journal:  Ann Surg Oncol       Date:  2020-02-25       Impact factor: 5.344

Review 7.  Esophageal carcinoma: Towards targeted therapies.

Authors:  Ali Fatehi Hassanabad; Rania Chehade; Daniel Breadner; Jacques Raphael
Journal:  Cell Oncol (Dordr)       Date:  2019-12-17       Impact factor: 6.730

8.  The significance of pathological extracapsular vs. intracapsular lymph node involvement in patients with resectable esophageal cancer after neoadjuvant therapy.

Authors:  Puja Gaur Khaitan; Thomas J Watson
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

9.  Nodal downstaging in esophageal and esophagogastric junction cancer: more important than ever.

Authors:  Andrea Zanoni
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

Review 10.  Dealing with the gray zones in the management of gastric cancer: The consensus statement of the İstanbul Group.

Authors:  Erman Aytaç; Fatih Aslan; Bahattin Çicek; Sibel Erdamar; Bengi Gürses; Koray Güven; Okan Falay; Tayfun Karahasanoğlu; Fatih Selçukbiricik; Uğur Selek; Banu Atalar; Emre Balık; Nurdan Tözün; İzzet Rozanes; Ali Arıcan; İsmail Hamzaoğlu; Bilgi Baca; Nil Molinas Mandel; Murat Saruç; Süha Göksel; Gökhan Demir; Fulya Ağaoğlu; Cengiz Yakıcıer; Uğur Özbek; Volkan Özben; Enis Özyar; Ahmet Levent Güner; Özlem Er; Kerim Kaban; Yasemin Bölükbaşı; Dursun Buğra; The İstanbul Group
Journal:  Turk J Gastroenterol       Date:  2019-07       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.